The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
Open accessAbstract
The increasing use of polymyxins1 in addition to the dissemination of plasmid-borne colistin resistance threatens to cause a serious breach in our last line of defence against multidrug-resistant Gram-negative pathogens, and heralds the emergence of truly pan-resistant infections. Colistin resistance often arises through covalent modification of lipid A with cationic residues such as phosphoethanolamine—as is mediated by Mcr-1 (ref. 2)—which reduce the affinity of polymyxins for lipopolysaccharide3. Thus, new strategies are needed to address the rapidly diminishing number of treatment options for Gram-negative infections4. The difficulty in eradicating Gram-negative bacteria is largely due to their highly impermeable outer membrane, which serves as a barrier to many otherwise effective antibiotics5. Here, we describe an unconventional screening platform designed to enrich for non-lethal, outer-membrane-active compounds with potential as adjuvants for conventional antibiotics. This approach identified the antiprotozoal drug pentamidine6 as an effective perturbant of the Gram-negative outer membrane through its interaction with lipopolysaccharide. Pentamidine displayed synergy with antibiotics typically restricted to Gram-positive bacteria, yielding effective drug combinations with activity against a wide range of Gram-negative pathogens in vitro, and against systemic Acinetobacter baumannii infections in mice. Notably, the adjuvant activity of pentamidine persisted in polymyxin-resistant bacteria in vitro and in vivo. Overall, pentamidine and its structural analogues represent unexploited molecules for the treatment of Gram-negative infections, particularly those having acquired polymyxin resistance determinants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationAgents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
The Pleiotropic Two-Component Regulatory System PhoP-PhoQ
Groisman, E. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.6.1835-1842.2001 · Cited by 887
Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology
Karp, P. D., Paley, S. M., Krummenacker, M., Latendresse, M., Dale, J. M., Lee, T. J., Kaipa, P., Gilham, F., Spaulding, A., Popescu, L., et al. (2010) · Briefings in Bioinformatics · doi:10.1093/bib/bbp043 · Cited by 694
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565
EcoCyc: fusing model organism databases with systems biology
Keseler, I. M., Mackie, A., Peralta-Gil, M., Santos-Zavaleta, A., Gama-Castro, S., Bonavides-Martínez, C., Fulcher, C., Huerta, A. M., Kothari, A., Krummenacker, M., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1027 · Cited by 542
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Self-citationNation, R. L., & Li, J. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328332e672 · Cited by 443
Hasman, H., Hammerum, A. M., Hansen, F., Hendriksen, R. S., Olesen, B., Agersø, Y., Zankari, E., Leekitcharoenphon, P., Stegger, M., Kaas, R. S., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.49.30085 · Cited by 419
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models
Clifton, L. A., Skoda, M. W. A., Le Brun, A. P., Ciesielski, F., Kuzmenko, I., Holt, S. A., & Lakey, J. H. (2015) · Langmuir · doi:10.1021/la504407v · Cited by 389
Sands, M., Kron, M. A., & Brown, R. B. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.5.625 · Cited by 348
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Pathway Tools version 19.0 update: software for pathway/genome informatics and systems biology
Karp, P. D., Latendresse, M., Paley, S. M., Krummenacker, M., Ong, Q. D., Billington, R., Kothari, A., Weaver, D., Lee, T., Subhraveti, P., et al. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv079 · Cited by 266
Polycations as outer membrane-disorganizing agents
Vaara, M., & Vaara, T. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.1.114 · Cited by 250
Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis
Mariam, D. H., Mengistu, Y., Hoffner, S. E., & Andersson, D. I. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1289-1294.2004 · Cited by 247
Pathway Databases: A Case Study in Computational Symbolic Theories
Karp, P. D. (2001) · Science · doi:10.1126/science.1064621 · Cited by 230
Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
Du, H., Chen, L., Tang, Y.-W., & Kreiswirth, B. N. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00056-6 · Cited by 226
Offense and defense: microbial membrane vesicles play both ways
MacDonald, I. A., & Kuehn, M. J. (2012) · Research in Microbiology · doi:10.1016/j.resmic.2012.10.020 · Cited by 192
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria
Band, V., & Weiss, D. (2014) · Antibiotics · doi:10.3390/antibiotics4010018 · Cited by 185
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus
O’Neill, A. J., Cove, J. H., & Chopra, I. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.647 · Cited by 123
David, S. A. (2001) · Journal of Molecular Recognition · doi:10.1002/jmr.549 · Cited by 116
Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
Napier, B. A., Burd, E. M., Satola, S. W., Cagle, S., Ray, S. M., McGann, P., Pohl, J., Lesho, E. P., & Weiss, D. S. (2013) · mBio · doi:10.1128/mbio.00021-13 · Cited by 108
Ofek, I., Cohen, S., Rahmani, R., Kabha, K., Tamarkin, D., Herzig, Y., & Rubinstein, E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.374 · Cited by 105
Discovery of a small molecule that inhibits bacterial ribosome biogenesis
Stokes, J. M., Davis, J. H., Mangat, C. S., Williamson, J. R., & Brown, E. D. (2014) · eLife · doi:10.7554/elife.03574 · Cited by 92
Self-citationPathway Tools version 28.0: Integrated Software for Pathway/Genome Informatics and Systems BiologyPreprint
Karp, P. D., Paley, S., Krummenacker, M., Kothari, A., Midford, P. E., Subhraveti, P., Swart, A., Moore, L. R., & Caspi, R. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1510.03964 · Cited by 84
Stokes, J. M., French, S., Ovchinnikova, O. G., Bouwman, C., Whitfield, C., & Brown, E. D. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.011 · Cited by 81
Self-citationA robust platform for chemical genomics in bacterial systems
French, S., Mangat, C. S., Bharat, A., Côté, J., Mori, H., & Brown, E. D. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-08-0573 · Cited by 69
Self-citationMiletti-González, K. E., & Leibowitz, M. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.958-966.2000 · Cited by 60
Antibacterial Drug Leads: DNA and Enzyme Multitargeting
Zhu, W., Wang, Y., Li, K., Gao, J., Huang, C.-H., Chen, C., Ko, T., Zhang, Y., Guo, R., & Oldfield, E. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501449u · Cited by 54
Mangat, C. S., Bharat, A., Gehrke, S. S., & Brown, E. D. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114534298 · Cited by 52
Self-citationEFFECT OF PENTAMIDINE ON THE GROWTH OF ESCHERICHIA COLI
Amos, H., & Vollmayer, E. (1957) · Journal of Bacteriology · doi:10.1128/jb.73.2.172-177.1957 · Cited by 24
Cited by
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Self-citationDrug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
The past, present, and future of antibiotics
Cook, M. A., & Wright, G. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7793 · Cited by 652
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
Plant Natural Flavonoids Against Multidrug Resistant Pathogens
Song, M., Liu, Y., Li, T., Liu, X., Hao, Z., Ding, S., Panichayupakaranant, P., Zhu, K., & Shen, J. (2021) · Advanced Science · doi:10.1002/advs.202100749 · Cited by 393
Metadata
- Authors
- Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., & Brown, E. D.
- Venue
- Nature Microbiology
- Published
- 2017-03-06
- Volume
- 2
- Issue
- 5
- Pages
- 17028-17028
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W2593939403
- Cited by
- 340
- References
- 41
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.